North American Scientific Inc.’s ClearPath is a
high-dose rate radiation treatment created for breast brachytherapy that aims to enhance current accelerated partial breast irradiation (APBI) treatment options.
The company’s multichannel catheter system, which is inserted through a single incision, is designed to allow for low-dose or high-dose therapy. The ClearPath system reportedly offers physicians greater flexibility in treatment planning and dose optimization to the target region while minimizing exposure to nearby healthy tissue.